Antiretroviral Adverse Drug Reaction Report form

To report a suspected adverse drug reaction (“side effect”) to an antiretroviral medication, download and complete the Antiretroviral Adverse Drug Reaction Report form and fax or mail it to the BC-CfE Pharmacovigilance Initiative (address shown on the top of the form).

To learn more about HIV drug safety monitoring and adverse drug reaction reporting, click here.

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025